18F-FDG PET/CT in immunocompetent patients with primary central nervous system lymphoma: Differentiation from glioblastoma and correlation with DWI
- PMID: 29857862
- DOI: 10.1016/j.ejrad.2018.04.020
18F-FDG PET/CT in immunocompetent patients with primary central nervous system lymphoma: Differentiation from glioblastoma and correlation with DWI
Abstract
Objectives: 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT) is useful for the detection of cancerous lesions, and FDG uptake is related to the apparent diffusion coefficient (ADC) derived from diffusion-weighted imaging (DWI) of extracranial tumors. The purpose of our study was to investigate the ability of FDG PET/CT in distinguishing primary central nervous system lymphoma (PCNSL) from glioblastoma multiforme (GBM) and to explore the relationship between 18F-FDG uptake and the ADC in patients with PCNSL.
Methods: We reviewed 92 patients (40 with PCNSL and 52 with GBM) who underwent FDG PET/CT scans at disease onset. The maximum standardized uptake value (SUVmax), tumor to normal contralateral cortex activity (T/N) ratio, SUVmean, metabolic tumor volume (MTV), and total lesion glycolysis (TLG) of tumor lesions were calculated. Receiver operating characteristic (ROC) curves were generated to determine the diagnostic performance for FDG PET-related parameters to differentiate PCNSL from GBM. Twenty-eight patients with PCNSL (with 34 lesions) also underwent diffusion-weighted imaging. Pearson's correlation analysis was used to assess the relation between SUV- and ADC-derived parameters.
Results: The SUVmax, T/N ratio, SUVmean, and TLG values were significantly higher in PCNSL than in GBM. Comparative ROC analysis indicated that the SUVmax had a greater area under the curve (AUC) of 0.910 than the T/N ratio (0.905, P = .85), SUVmean (0.836, P = .0006), or TLG (0.641, P < 0.0001). The T/N ratio had the highest specificity (94.23%) for differentiating PCNSL from GBM, while the SUVmax had the most optimal sensitivity (92.31%). Further combined analysis of the indices did not significantly improve the AUC. Moderate inverse correlations between the SUVmax, SUVmean, TLG, and the ADC ratio (rADC) were found in PCNSLs (r = -0.526, P = .002; r = -0.504, P = .004; and r = -0.483, P = .006; respectively).
Conclusions: The SUVmax and T/N ratio may be reliable measures for differentiating PCNSLs from GBMs. Additionally, FDG metabolism indices were inversely proportional to the rADCs of PCNSL lesions.
Keywords: Diffusion weighted imaging; FDG; Glioblastoma multiforme; PET/CT; Primary central nervous system lymphoma.
Copyright © 2018 Elsevier B.V. All rights reserved.
Similar articles
-
Diagnostic utility of intravoxel incoherent motion mr imaging in differentiating primary central nervous system lymphoma from glioblastoma multiforme.J Magn Reson Imaging. 2016 Nov;44(5):1256-1261. doi: 10.1002/jmri.25261. Epub 2016 Apr 19. J Magn Reson Imaging. 2016. PMID: 27093558
-
18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.Invest Radiol. 2016 Mar;51(3):163-9. doi: 10.1097/RLI.0000000000000218. Invest Radiol. 2016. PMID: 26784400 Free PMC article.
-
[Usefulness and limitation of FDG-PET in the diagnosis of primary central nervous system lymphoma].No Shinkei Geka. 2013 Feb;41(2):117-26. No Shinkei Geka. 2013. PMID: 23378387 Japanese.
-
Hyperaccumulation of (18)F-FDG in order to differentiate solid pseudopapillary tumors from adenocarcinomas and from neuroendocrine pancreatic tumors and review of the literature.Hell J Nucl Med. 2013 May-Aug;16(2):97-102. doi: 10.1967/s002449910084. Epub 2013 May 20. Hell J Nucl Med. 2013. PMID: 23687644 Review.
-
Comparison of diffusion-weighted MRI and [18F]FDG PET/MRI for treatment monitoring in pediatric Hodgkin and non-Hodgkin lymphoma.Eur Radiol. 2024 Jan;34(1):643-653. doi: 10.1007/s00330-023-10015-5. Epub 2023 Aug 5. Eur Radiol. 2024. PMID: 37542653 Free PMC article. Review.
Cited by
-
Progress of radiological‑pathological workflows in the differential diagnosis between primary central nervous system lymphoma and high‑grade glioma (Review).Oncol Rep. 2023 Jan;49(1):20. doi: 10.3892/or.2022.8457. Epub 2022 Dec 9. Oncol Rep. 2023. PMID: 36484403 Free PMC article.
-
Predictors for the Differentiation between Glioblastoma, Primary Central Nervous System Lymphoma, and Metastasis in Patients with a Solitary Enhancing Intracranial Mass.Asian J Neurosurg. 2024 Jun 6;19(2):186-201. doi: 10.1055/s-0044-1787051. eCollection 2024 Jun. Asian J Neurosurg. 2024. PMID: 38974428 Free PMC article.
-
18F-FDG-PET-based radiomics features to distinguish primary central nervous system lymphoma from glioblastoma.Neuroimage Clin. 2019;23:101912. doi: 10.1016/j.nicl.2019.101912. Epub 2019 Jun 27. Neuroimage Clin. 2019. PMID: 31491820 Free PMC article.
-
Diagnostic Accuracy of the Diffusion-Weighted Imaging Method Used in Association With the Apparent Diffusion Coefficient for Differentiating Between Primary Central Nervous System Lymphoma and High-Grade Glioma: Systematic Review and Meta-Analysis.Front Neurol. 2022 Jun 24;13:882334. doi: 10.3389/fneur.2022.882334. eCollection 2022. Front Neurol. 2022. PMID: 35812103 Free PMC article.
-
Machine Learning in Differentiating Gliomas from Primary CNS Lymphomas: A Systematic Review, Reporting Quality, and Risk of Bias Assessment.AJNR Am J Neuroradiol. 2022 Apr;43(4):526-533. doi: 10.3174/ajnr.A7473. Epub 2022 Mar 31. AJNR Am J Neuroradiol. 2022. PMID: 35361577 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources